Literature DB >> 19669613

Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study.

Carlo Colosimo1, Letterio Morgante, Angelo Antonini, Paolo Barone, Tania P Avarello, Edo Bottacchi, Antonino Cannas, Maria Gabriella Ceravolo, Roberto Ceravolo, Giulio Cicarelli, Rosa M Gaglio, Luisa Giglia, Francesco Iemolo, Michela Manfredi, Giuseppe Meco, Alessandra Nicoletti, Massimo Pederzoli, Alfredo Petrone, Antonio Pisani, Francesco E Pontieri, Rocco Quatrale, Silvia Ramat, Rossana Scala, Giampiero Volpe, Salvatore Zappulla, Anna Rita Bentivoglio, Fabrizio Stocchi, Giorgio Trianni, Paolo Del Dotto, Lucia Simoni, Roberto Marconi.   

Abstract

The PRIAMO study is a cross-sectional longitudinal observational study aimed at describing epidemiology and evolution of non-motor symptoms (NMS) in patients with different forms of parkinsonism recruited in 55 Italian centres and evaluated over 24 months. In this paper, we are reporting prevalence and clinical characteristics of NMS in patients with atypical and secondary parkinsonism. Out of 1307 consecutive patients with a diagnosis of parkinsonism, 83 patients had vascular parkinsonism (VP), 34 had multiple system atrophy (MSA), 30 had progressive supranuclear palsy (PSP), 14 had dementia with Lewy bodies (DLB) and 11 had corticobasal degeneration (CBD). MSA and DLB had the highest number of NMS domains and symptoms, respectively. Gastrointestinal symptoms, pain, urinary problems and postural instability due to orthostatic hypotension were most frequent in MSA. Sleep disturbances were also common with a prevalence of approximately 70% in all diagnostic groups but CBD (36%). Psychiatric symptoms and attention and memory impairment were frequently observed in all diagnoses but were most prevalent among DLB patients, whereas the prevalence of skin and respiratory disorders was rather low in all forms, ranging between 10 and 30%. Atypical parkinsonism patients also reported a low QoL, with no significant differences among the different forms, whereas PD and VP patients had a better QoL.

Entities:  

Mesh:

Year:  2009        PMID: 19669613     DOI: 10.1007/s00415-009-5255-7

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  29 in total

Review 1.  Parkinsonism: a review-of-systems approach to diagnosis.

Authors:  Paul J Tuite; Kimberly Krawczewski
Journal:  Semin Neurol       Date:  2007-04       Impact factor: 3.420

2.  Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores.

Authors:  Eugenia Mamikonyan; Paul J Moberg; Andrew Siderowf; John E Duda; Tom Ten Have; Howard I Hurtig; Matthew B Stern; Daniel Weintraub
Journal:  Parkinsonism Relat Disord       Date:  2008-07-02       Impact factor: 4.891

3.  The Frontal Assessment Battery (FAB): normative values in an Italian population sample.

Authors:  I Appollonio; M Leone; V Isella; F Piamarta; T Consoli; M L Villa; E Forapani; A Russo; P Nichelli
Journal:  Neurol Sci       Date:  2005-06       Impact factor: 3.307

4.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

5.  The FAB: a Frontal Assessment Battery at bedside.

Authors:  B Dubois; A Slachevsky; I Litvan; B Pillon
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

6.  Pain in multiple system atrophy.

Authors:  F Tison; G K Wenning; M A Volonte; W R Poewe; P Henry; N P Quinn
Journal:  J Neurol       Date:  1996-02       Impact factor: 4.849

7.  Oral and genital pain syndromes in Parkinson's disease.

Authors:  B Ford; E D Louis; P Greene; S Fahn
Journal:  Mov Disord       Date:  1996-07       Impact factor: 10.338

Review 8.  Update of atypical Parkinsonian disorders.

Authors:  Irene Litvan
Journal:  Curr Opin Neurol       Date:  2007-08       Impact factor: 5.710

9.  Second consensus statement on the diagnosis of multiple system atrophy.

Authors:  S Gilman; G K Wenning; P A Low; D J Brooks; C J Mathias; J Q Trojanowski; N W Wood; C Colosimo; A Dürr; C J Fowler; H Kaufmann; T Klockgether; A Lees; W Poewe; N Quinn; T Revesz; D Robertson; P Sandroni; K Seppi; M Vidailhet
Journal:  Neurology       Date:  2008-08-26       Impact factor: 9.910

10.  Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study.

Authors:  Gilbert Bensimon; Albert Ludolph; Yves Agid; Marie Vidailhet; Christine Payan; P Nigel Leigh
Journal:  Brain       Date:  2008-11-23       Impact factor: 13.501

View more
  40 in total

1.  A cross-sectional study on drug use in multiple system atrophy.

Authors:  María Verónica Rey; Santiago Perez-Lloret; Anne Pavy-Le Traon; Wassilios G Meissner; Francois Tison; Olivier Rascol
Journal:  CNS Drugs       Date:  2014-05       Impact factor: 5.749

Review 2.  Neuropathobiology of non-motor symptoms in Parkinson disease.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2015-05-15       Impact factor: 3.575

Review 3.  Cognitive impairment in multiple system atrophy: a position statement by the Neuropsychology Task Force of the MDS Multiple System Atrophy (MODIMSA) study group.

Authors:  Iva Stankovic; Florian Krismer; Aleksandar Jesic; Angelo Antonini; Thomas Benke; Richard G Brown; David J Burn; Janice L Holton; Horacio Kaufmann; Vladimir S Kostic; Helen Ling; Wassilios G Meissner; Werner Poewe; Marija Semnic; Klaus Seppi; Atsushi Takeda; Daniel Weintraub; Gregor K Wenning
Journal:  Mov Disord       Date:  2014-04-18       Impact factor: 10.338

Review 4.  Nonmotor presentations of multiple system atrophy.

Authors:  Carlo Colosimo
Journal:  Nat Rev Neurol       Date:  2011-02-22       Impact factor: 42.937

5.  Depressive Symptoms are Frequent in Atypical Parkinsonian Disorders.

Authors:  Leonardo Almeida; Bilal Ahmed; Roger Walz; Sol De Jesus; Addie Patterson; Daniel Martinez-Ramirez; David Vaillancourt; Dawn Bowers; Herbert Ward; Michael S Okun; Nikolaus R McFarland
Journal:  Mov Disord Clin Pract       Date:  2016-06-24

Review 6.  Gray matter atrophy in progressive supranuclear palsy: meta-analysis of voxel-based morphometry studies.

Authors:  Hai Cun Shi; Jian Guo Zhong; Ping Lei Pan; Pei Rong Xiao; Yuan Shen; Li Juan Wu; Hua Liang Li; Yuan Ying Song; Gui Xiang He; Hong Ye Li
Journal:  Neurol Sci       Date:  2013-03-30       Impact factor: 3.307

7.  Midlife migraine and late-life parkinsonism: AGES-Reykjavik study.

Authors:  Ann I Scher; G Webster Ross; Sigurdur Sigurdsson; Melissa Garcia; Larus S Gudmundsson; Sigurlaug Sveinbjörnsdóttir; Amy K Wagner; Vilmundur Gudnason; Lenore J Launer
Journal:  Neurology       Date:  2014-09-17       Impact factor: 9.910

8.  Autopsy confirmed multiple system atrophy cases: Mayo experience and role of autonomic function tests.

Authors:  Valeria Iodice; Axel Lipp; J Eric Ahlskog; Paola Sandroni; Robert D Fealey; Joseph E Parisi; Joseph Y Matsumoto; Eduardo E Benarroch; Kurt Kimpinski; Wolfgang Singer; Tonette L Gehrking; Jade A Gehrking; David M Sletten; Ann M Schmeichel; James H Bower; Sid Gilman; Juan Figueroa; Phillip A Low
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-01-06       Impact factor: 10.154

9.  TDP-43 pathology occurs infrequently in multiple system atrophy.

Authors:  F Geser; J A Malunda; H I Hurtig; J E Duda; G K Wenning; S Gilman; P A Low; V M-Y Lee; J Q Trojanowski
Journal:  Neuropathol Appl Neurobiol       Date:  2011-06       Impact factor: 8.090

10.  Nocturnal manifestations of atypical and vascular parkinsonism: how do they differ from Parkinson's disease?

Authors:  Roongroj Bhidayasiri; Onanong Jitkritsadakul; Sitthi Petchrutchatachart; Lalita Kaewwilai; Pattamon Panyakaew; Nonglak Boonrod; Carlo Colosimo
Journal:  J Neural Transm (Vienna)       Date:  2014-03-26       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.